US Stock MarketDetailed Quotes

CAPR Capricor Therapeutics

Watchlist
  • 18.620
  • +0.830+4.67%
Close Nov 22 16:00 ET
  • 18.500
  • -0.120-0.64%
Post 20:01 ET
846.65MMarket Cap-18254P/E (TTM)

Capricor Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Capricor Therapeutics Q3 2024 Earnings Date

Currency：USDNov 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
3.57M
2.26M
-1.31M
Miss Est.
-42.31%
-63.44%
-36.62%
EPS
-0.36
-0.38
-0.02
Miss Est.
-43.34%
-52.00%
-6.09%
Analyst Rating
Strong Buy

Nov 18, 2024

Capricor Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.167M--
--2024/Q4-- / 9.870M--
Nov 13, 20242024/Q32.262M / 3.568M--
Aug 7, 20242024/Q23.971M / 3.664M--
May 13, 20242024/Q14.907M / 9.700M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.167M--
--2024/Q4-- / 9.870M--
Nov 13, 20242024/Q32.262M / 3.568M--
Aug 7, 20242024/Q23.971M / 3.664M--
May 13, 20242024/Q14.907M / 9.700M--

Unlock Free Earnings Estimates

Capricor Therapeutics Earnings Reports

  • Capricor Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 14 16:36 ET

  • Capricor Therapeutics | 8-K: Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

    Nov 13 16:09 ET

  • Capricor Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 17:06 ET

  • Capricor Therapeutics | 8-K: Capricor Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

    Aug 7 16:13 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 18, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data